Scandonest® 3% plain 

3% mepivacaine HCL to provide local anesthesia without the use of vasoconstrictors for specific clinical situations.

precision

Terminal sterilization

Clean

Paraben free and no natural rubber latex

Safety

No vasoconstrictors

  • Indications

    Local dental anesthesia by infiltration or nerve block in adults and pediatric patients. 

  • Features & benefits

    • Formulation without vaso-constrictor for specific clinical situations. 
    • Fast onset: 30 to 120 seconds in the maxilla and 1 to 4 minutes for the mandible. 
    • Duration: will ordinarily provide pulpal anesthesia of about 20 minutes in the maxilla, and about 40 minutes in the mandible. 
    • No-methylparaben formulation to avoid allergic reactions on sensitive patients. 
    • No natural rubber latex components to help reduce allergic responses. 
    • Terminal sterilization of product/cartridges for safe use. 
    • Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakage. 
    • Cartridges packed 10 to a blister tray to avoid glass to glass contact, hence reducing breakage. 
  • Ordering information

    Item #01A1003 – Box containing 5 blisters of 10 x 1.7ml glass cartridges 

  • Safety information

    Reactions to Scandonest® are characteristic of those associated with other amide-type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, inadvertent intravascular injection or slow metabolic degradation. Scandonest® is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of mepivacaine solutions. Local anesthetics should be employed only by clinicians who are well versed in diagnosis and management of dose-related toxicity and other acute emergencies which might arise from the block to be employed, and then only after insuring the immediate availability of oxygen, other resuscitative drugs, cardiopulmonary resuscitative equipment, and the personnel resources needed for proper management of toxic reactions and related emergencies. Scandonest® 2% L contains potassium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Please see package insert for prescribing information. 

  • Documentation

Key figures about this product

Fast onset

As from 30 seconds in the maxilla and 1 minute for the mandible

Short duration

20 minutes in the maxilla, 40 minutes in the mandible

0

No natural rubber latex - 0% methylparabens

You may wonder

  • Does Scandonest® 3% plain contain alcohol?

    None of the ingredients of our product Scandonest® 3% plain are an evident source of alcohol.

  • Does Scandonest® 3% plain contain gluten?

    None of the ingredients of our product Scandonest® 3% plain are an evident source of gluten.

  • Does Scandonest® 3% plain contain peanut, soy or nut?

    None of the ingredients of our product Scandonest® 3% plain are an evident source of peanut, soy or nut.

  • Does the product contain a vasoconstrictor?

    Our product Scandonest 30 mg/mL does not contain vasoconstrictor.

product-faqs

You may also need

Register for free
1/4 Choose your login information

Your password must contain at least:

8 characters

A number and a letter

A special character

2/4 Enter your personal information
4/4 Confirm

Register for free

Sign up now and get an exclusive access to:

  • Live webinars and webinar replays to learn from the best speakers in dentistry.
  • Educational content in a variety of formats (articles, podcasts, clinical cases, videos, and more) to enhance your skills and achieve business success.
  • Our Voice of Customer program to contribute in creating innovative products that address your needs.
Create an account
Sign up now Already a member? Log-in!
Forgot your password?

Enter your email address below.

We will send you a password reset link by email.

Cancel
Subscribe to our Newsletter